Oncolytics Biotech Inc T.ONC

Big Pharma Amgen pays US$2 Billion for Phase 1 company

[Noteable]

January 05, 2023 - Amgen starts the new year with a bang, licensing-in Synaffix Phase-1 ADC technology for US $2 billion - the largest ADC licensing deal to date.

https://endpts.com/amgen-kicks-off-2023-dealmaking-with-busy-adc-upstart-synaffix/

[westcoast1000]

Noteable, Is there any information or trials that indicate how well, or if, pela synergizes with or improves the benefits of ADCs?

[Noteable]

Repost : - January 05, 2023 - Amgen starts the new year with a bang, licensing-in Synaffix Phase-1 ADC technology for US $2 billion - the largest ADC licensing deal to date. ......................... Conversely ONCY is a "Phase 3 ready" company with a predicitive diagnostic that is demonstrating to be effective in multiple cancers including pancreatic and breast cancers